Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 351

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

Sacral Nerve Stimulation for Fecal Incontinence: Results of a 120-Patient Prospective Multicenter Study

Wexner, Steven D., Coller, John A., Devroede, Ghislain, Hull, Tracy, McCallum, Richard, Chan, Miranda, Ayscue, Jennifer M., Shobeiri, Abbas S., Margolin, David, England, Michael, Kaufman, Howard, Snape, William J., Mutlu, Ece, Chua, Heidi, Pettit, Paul, Nagle, Deborah, Madoff, Robert D., Lerew, Darin R., Mellgren, Anders·2010·Annals of Surgery

Abstract

In Brief Background: Sacral nerve stimulation has been approved for use in treating urinary incontinence in the United States since 1997, and in Europe for both urinary and fecal incontinence (FI) since 1994. The purpose of this study was to determine the safety and efficacy of sacral nerve stimulation in a large population under the rigors of Food and Drug Administration-approved investigational protocol. Methods: Candidates for SNS who provided informed consent were enrolled in this Institutional Review Board-approved multicentered prospective trial. Patients showing ≥50% improvement during test stimulation received chronic implantation of the InterStim Therapy (Medtronic; Minneapolis, MN). The primary efficacy objective was to demonstrate that ≥50% of subjects would achieve therapeutic success, defined as ≥50% reduction of incontinent episodes per week at 12 months compared with baseline. Results: A total of 133 patients underwent test stimulation with a 90% success rate, and 120 (110 females) of a mean age of 60.5 years and a mean duration of FI of 6.8 years received chronic implantation. Mean follow-up was 28 (range, 2.2–69.5) months. At 12 months, 83% of subjects achieved therapeutic success (95% confidence interval: 74%–90%; P < 0.0001), and 41% achieved 100% continence. Therapeutic success was 85% at 24 months. Incontinent episodes decreased from a mean of 9.4 per week at baseline to 1.9 at 12 months and 2.9 at 2 years. There were no reported unanticipated adverse device effects associated with InterStim Therapy. Conclusion: Sacral nerve stimulation using InterStim Therapy is a safe and effective treatment for patients with FI. The purpose of this study was to determine the safety and efficacy of SNS in a large population under the rigors of an FDA-approved investigational protocol. 133 patients underwent test stimulation with a 90% success rate, and 120 (110 females), of a mean age of 60.5 years and a mean FI duration of 6.8 years, received chronic implantation. Sacral nerve stimulation using IterStim Therapy is a safe and effective treatment for patients with FI.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/sla.0b013e3181cf8ed0

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 36 references

Cited by

See all 351

Metadata

Authors
Wexner, S. D., Coller, J. A., Devroede, G., Hull, T., McCallum, R., Chan, M., Ayscue, J. M., Shobeiri, A. S., Margolin, D., England, M., Kaufman, H., Snape, W. J., Mutlu, E., Chua, H., Pettit, P., Nagle, D., Madoff, R. D., Lerew, D. R., & Mellgren, A.
Venue
Annals of Surgery
Published
2010-03
Volume
251
Issue
3
Pages
441-449
ISSN
0003-4932 (ISSN-L)
OpenAlex
W2011144550
Cited by
351
References
36
FWCI
19.67
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Sacral Nerve Stimulation for Fecal Incontinence: Results of a 120-Patient Prospective Multicenter Study. https://app.cochat.ai/papers/10.1097/sla.0b013e3181cf8ed0
The paper
Wexner, S. D., Coller, J. A., Devroede, G., Hull, T., McCallum, R., Chan, M., Ayscue, J. M., Shobeiri, A. S., Margolin, D., England, M., Kaufman, H., Snape, W. J., Mutlu, E., Chua, H., Pettit, P., Nagle, D., Madoff, R. D., Lerew, D. R., & Mellgren, A. (2010). Sacral Nerve Stimulation for Fecal Incontinence: Results of a 120-Patient Prospective Multicenter Study. Annals of Surgery. https://doi.org/10.1097/sla.0b013e3181cf8ed0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.